Major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia - 12 years of progress: An observational study

Clinical Infectious Diseases

Volumn 59, Issue 7, 2014, Pages 969-975

  Mitchell, Brett G ^a,b   Collignon, Peter J ^c   McCann, Rebecca ^d   Wilkinson, Irene J ^e   Wells, Anne ^f  

^a AVONDALE COLLEGE OF HIGHER EDUCATION   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e Department of Health Infection Control Service   (Australia)

^f NONE   (Australia)

Author keywords

Bacteremia; Bloodstream infection; Healthcare associated infections; Infection control; Staphylococcus aureus

Indexed keywords

ARTICLE; AUSTRALIA; DISEASE SURVEILLANCE; HOSPITAL INFECTION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; BACTEREMIA; BLOOD; CROSS INFECTION; HOSPITAL; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; PROSPECTIVE STUDY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

AUSTRALIA; BACTEREMIA; BLOOD; CROSS INFECTION; HOSPITALS; HUMANS; INCIDENCE; INFECTION CONTROL; LONGITUDINAL STUDIES; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84918530208     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu508     Document Type: Article

References (32)

1. Kohn L, Corrigan J, Donaldson M, eds. To err is human: building a safer health system. Washington: National Academy Press, 1999.
2. Yokoe D, Classen D. Introduction: improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 2008; 29(suppl 1): S3-11.
3. Flanagan ME, Welsh CA, Kiess C, Hoke S, Doebbeling BN. A national collaborative for reducing health care associated infections: current initiatives, challenges, and opportunities. Am J Infect Control 2011; 39:685-9.
4. Weinstein RA, Edmond M, Eickhoff TC. Who is steering the ship? external influences on infection control programs. Clin Infect Dis 2008; 46:1746-50.
5. Wyllie DH, Crook DW, Peto TEA. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. Br Med J 2006; 333:281-4
6. [Erratum: BMJ 2006; 333:468.]
7. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-35.
8. Turnidge J, Kotsanas D, MunckhofW, et al; Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191:368-73.
9. de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8:e1001104.
10. Mitchell BG, Gardner A. Addressing the need for an infection prevention and control framework that incorporates the role of surveillance: a discussion paper. J Adv Nurs 2014; 70:533-42.
11. Collignon P, Dreimanis D, BeckinghamW, Roberts J, Gardner A. Intravascular catheter bloodstream infections: an effective and sustained hospitalwide prevention program over 8 years. Med J Aust 2007; 187:551-4.
12. Stone SP, Fuller C, Savage J, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. Br Med J 2012; 344:e3005.
13. Grayson L, Russo R, Cruickshank M, et al. Outcomes from the first 2 years of the Australian National Hand Hygiene Initiative. Med J Aust 2011; 195:615-9.
14. Allegranzi B, Nejad SB, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011; 377:228-41.
15. Mejer N, Westh H, Schønheyder H, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis 2012; 12:1-7.
16. Collignon P, Nimmo G, Gottlieb T, Gosbell I; Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 2005; 11:554-61.
17. Australian Institute of Health andWelfare. Australian hospital statistics 2011-12. In: Australian Institute of Health andWelfare. Canberra: Australian Government, 2013.
18. Australian Commission on Safety and Quality in Health Care. Data set specification: version 4.0 surveillance of healthcare associated infections: Staphylococcus aureus bacteraemia and Clostridiumdifficile infection. Sydney: Australian Commission on Safety and Quality in Health Care, 2010.
19. Independent Pricing Authority. Appendix B: AIHW peer group classification for Australian public hospitals. Canberra: Independent Pricing Authority, 2013.
20. Lawes T, Edwards B, Lopez-Lozano JM, Gould I. Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis. BMJ Open 2012; 2:e000797.
21. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother 2011; 66:2199-214.
22. Health Protection Agency. Financial year counts and rates of MRSA bacteraemia by NHS Acute Trust (FY 2008/09-FY 2012/13). Available at: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb- C/1233906819629. Accessed 24 September 2013.
23. Health Protection Agency. Financial year MSSA bacteraemia counts and rates (FY 2011/2012-2012/2013). Available at: http://www.hpa. org.uk/webw/HPAweb&HPAwebStandard/HPAweb-C/1317134949.648. Accessed 24 September 2013.
24. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364:1419-30.
25. Kallen AJ, Mu Y, Bulens S, et al. Healthcare-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304:641-7.
26. Laupland KB, Lyytikäinen O, Søgaard M, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013; 19:465-71.
27. Worth LJ, Spelman T, Bull A, Richards M. Staphylococcus aureus bloodstream infection in Australian hospitals: findings from a Victorian surveillance system. Med J Aust 2014; 200:282-4.
28. Cruickshank M, Murphy C, ed. Reducing harm to patients from healthcare associated infections: an Australian infection prevention and control model for acute hospitals. Sydney: Australian Commission on Safety and Quality in Health Care, 2009.
29. Bull A, Wilson J, Worth LJ, et al. A bundle of care to reduce colorectal surgical infections: an Australian experience. J Hosp Infect 2011; 78:297-301.
30. Australian Institute of Health andWelfare. Australian hospital statistics 2011-12. Canberra: Australian Institute of Health and Welfare.
31. Mitchell BG, Gardner A, Stewart L. The epidemiology of Staphylococcus aureus bacteraemia in Tasmania. Healthc Infect 2012; 17: 98-103.
32. Mitchell B, Gardner A, Collignon P, Stewart L, Cruickshank M. A literature review supporting the proposed national Australian definition for Staphylococcus aureus bacteraemia. Healthc Infect 2010; 15: 105-13.